| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.36 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |